Effects of St. John’s Wort Extract and Single Constituents on Stress-Induced Hyperthermia in Mice

 

 Buy Article Permissions and Reprints

Abstract

Emotional or stress-induced hyperthermia (SIH) is the rise of body temperature following exposure to psychological stress and has been demonstrated across species. In the present experiments we used exposure to an open field (OF) as inescapable stressor. Exposure of male BL6/C57J mice to OF stress significantly increased body temperature (ΔT = 1.8 ± 0.13 °C, p < 0.05). SIH is calculated as the difference (ΔT = T₂ - T₁) between the basal temperature (T₁) and the temperature after exposure to an OF for 10 min (T₂). Using this experimental design, St. John’s wort extract (SJW) as well as various single compounds of it were tested for their ability to affect ΔT. Anxiolytic drugs (the benzodiazepine diazepam; 5 mg/kg, and the 5HT_1A receptor agonist buspirone; 10 mg/kg) significantly reduced ΔT, whereas antidepressants (imipramine and fluoxetine) had no effect on ΔT. Oral administration of SJW extract significantly reduced ΔT in doses of 250 and 500 mg/kg. Higher (750 and 1000 mg/kg) as well as a lower dose (125 mg/kg) did not affect ΔT after stress, indicating a U-shaped dose-response curve. Hypericin (0.1 mg/kg, p. o.) administered 60 min prior to testing significantly decreased ΔT (p < 0.05) whereas hyperforin (1 - 10 mg/kg, p. o.) had no effect in this test paradigm. The flavonoids hyperoside, isoquercitrin and quercitrin (all at 0.6 mg/kg, p. o.) and rutin (1 mg/kg, p. o.) only partially blocked OF-induced hyperthermia. If compared to all other flavonoids, the quercetin 3-O-glucuronide miquelianin (1.2 mg/kg, p. o.) was the most potent compound tested in this experimental design. From the biflavonoids in SJW, only amentoflavone decreased SIH-induced hyperthermia in a dosage of 0.1 mg/kg. In conclusion, using open field stress as a psychological stressor to induce hyperthermia in mice we were able to detect putative anxiolytic effects of SJW extract and single consituents.

Abbreviations

ANOVA:analysis of variance

GABA:γ-amino-butyric acid

5-HT:5-hydroxytryptamine

OF:open field

SIH:stress-induced hyperthermia

SJW:St. John’s wort

References

• 1 Esch T, Stefano G B, Fricchione G L, Benson H. The role of stress in neurodegenerative diseases and mental disorders.  Neuro Endocrinol Lett. 2002;  23 199-208
  PubMedGoogle Scholar
• 2 Oka T, Oka K, Hori T. Mechanisms and mediators of psychological stress-induced rise in core temperature.  Psychosom Med. 2001;  63 476-86
  PubMedGoogle Scholar
• 3 Borsini F, Lecci A, Volterra G, Meli A. A model to measure anticipatory anxiety in mice?.  Psychopharmacology (Berl). 1989;  98 207-11
  CrossrefPubMedGoogle Scholar
• 4 Briese E. Emotional hyperthermia and performance in humans.  Physiol Behav. 1995;  58 615-8
  CrossrefPubMedGoogle Scholar
• 5 Lecci A, Borsini F, Volterra G, Meli A. Pharmacological validation of a novel animal model of anticipatory anxiety in mice.  Psychopharmacology (Berl). 1990;  101 255-61
  CrossrefPubMedGoogle Scholar
• 6 Zethof T J, Van der Heyden J A, Tolboom J T, Olivier B. Stress-induced hyperthermia in mice: A methodological study.  Physiol Behav. 1994;  55 109-15
  CrossrefPubMedGoogle Scholar
• 7 Van der Heyden J A, Zethof T J, Olivier B. Stress-induced hyperthermia in singly housed mice.  Physiol Behav. 1997;  62 463-70
  CrossrefPubMedGoogle Scholar
• 8 Liu X, Peprah D, Gershenfeld H K. Tail-suspension induced hyperthermia: A new measure of stress reactivity.  J Psychiatr Res. 2003;  37 249-59
  CrossrefPubMedGoogle Scholar
• 9 Butterweck V, Prinz S, Schwaninger M. The role of interleukin-6 in stress-induced hyperthermia and emotional behaviour in mice.  Behav Brain Res. 2003;  144 49-56
  CrossrefPubMedGoogle Scholar
• 10 Singer R, Harker C T, Vander A J, Kluger M J. Hyperthermia induced by open-field stress is blocked by salicylate.  Physiol Behav. 1986;  36 1179-82
  CrossrefPubMedGoogle Scholar
• 11 Behnke K, Jensen G S, Graubaum H J, Gruenwald J. Hypericum perforatum versus fluoxetine in the treatment of mild to moderate depression.  Adv Ther. 2002;  19 43-52
  CrossrefPubMedGoogle Scholar
• 12 Bjerkenstedt L, Edman G V, Alken R G, Mannel M. Hypericum extract LI 160 and fluoxetine in mild to moderate depression: A randomized, placebo-controlled multi-center study in outpatients.  Eur Arch Psychiatry Clin Neurosci. 2005;  255 40-7
  CrossrefPubMedGoogle Scholar
• 13 Gastpar M, Singer A, Zeller K. Efficacy and tolerability of Hypericum extract STW3 in long-term treatment with a once-daily dosage in comparison with sertraline.  Pharmacopsychiatry. 2005;  38 78-86
  Article in Thieme ConnectPubMedGoogle Scholar
• 14 Philipp M, Kohnen R, Hiller K O. Hypericum extract versus imipramine or placebo in patients with moderate depression: Randomised multicentre study of treatment for eight weeks.  Br Med J. 1999;  319 1534-8
  PubMedGoogle Scholar
• 15 Nahrstedt A, Butterweck V. Biologically active and other chemical constituents of the herb of Hypericum perforatum L.  Pharmacopsychiatry. 1997;  30 Suppl 2 129-34
  PubMedGoogle Scholar
• 16 Davidson J R, Connor K M. St. John's wort in generalized anxiety disorder: Three case reports.  J Clin Psychopharmacol. 2001;  21 635-6
  CrossrefPubMedGoogle Scholar
• 17 Taylor L H, Kobak K A. An open-label trial of St. John's wort (Hypericum perforatum) in obsessive-compulsive disorder.  J Clin Psychiatry. 2000;  61 575-8
  PubMedGoogle Scholar
• 18 Beijamini V, Andreatini R. Effects of Hypericum perforatum and paroxetine on rat performance in the elevated T-maze.  Pharmacol Res. 2003;  48 199-207
  CrossrefPubMedGoogle Scholar
• 19 Vandenbogaerde A, Zanoli P, Puia G, Truzzi C, Kamuhabwa A, De Witte P. et al . Evidence that total extract of Hypericum perforatum affects exploratory behavior and exerts anxiolytic effects in rats.  Pharmacol Biochem Behav. 2000;  65 627-33
  CrossrefPubMedGoogle Scholar
• 20 Olivier B, Zethof T, Pattij T, van Boogaert M, van Oorschot R, Leahy C. et al . Stress-induced hyperthermia and anxiety: Pharmacological validation.  Eur J Pharmacol. 2003;  463 117-32
  CrossrefPubMedGoogle Scholar
• 21 Jurgenliemk G, Nahrstedt A. Phenolic compounds from Hypericum perforatum .  Planta Med. 2002;  68 88-91
  Article in Thieme ConnectPubMedGoogle Scholar
• 22 Butterweck V, Jurgenliemk G, Nahrstedt A, Winterhoff H. Flavonoids from Hypericum perforatum show antidepressant activity in the forced swimming test.  Planta Med. 2000;  66 3-6
  Article in Thieme ConnectPubMedGoogle Scholar
• 23 Marazziti D, Di Muro A, Castrogiovanni P. Psychological stress and body temperature changes in humans.  Physiol Behav. 1992;  52 393-5
  CrossrefPubMedGoogle Scholar
• 24 Calabrese E J, Baldwin L A. U-shaped dose-responses in biology, toxicology and public health.  Annu Rev Public Health. 2001;  22 15-33
  CrossrefPubMedGoogle Scholar
• 25 Baureithel K H, Buter K B, Engesser A, Burkard W, Schaffner W. Inhibition of benzodiazepine binding in vitro by amentoflavone, a constituent of various species of Hypericum .  Pharm Acta Helv. 1997;  72 153-7
  PubMedGoogle Scholar
• 26 Hansen R S, Paulsen I, Davies M. Determinants of amentoflavone interaction at the gaba(a) receptor.  Eur J Pharmacol. 2005;  519 199-207
  CrossrefPubMedGoogle Scholar
• 27 Nielsen M, Frokjaer S, Braestrup C. High affinity of the naturally-occurring biflavonoid, amentoflavon, to brain benzodiazepine receptors in vitro .  Biochem Pharmacol. 1988;  37 3285-7
  CrossrefPubMedGoogle Scholar
• 28 Butterweck V, Nahrstedt A, Evans J, Hufeisen S, Rauser L, Savage J. et al . In vitro receptor screening of pure constituents of st. John's wort reveals novel interactions with a number of GPCRs.  Psychopharmacology (Berl). 2002;  162 193-202
  CrossrefPubMedGoogle Scholar
• 29 Zanoli P, Rivasi M, Baraldi C, Baraldi M. Pharmacological activity of hyperforin acetate in rats.  Behav Pharmacol. 2002;  13 645-51
  PubMedGoogle Scholar
• 30 Butterweck V, Winterhoff H, Herkenham M. St John's wort, hypericin, and imipramine: A comparative analysis of mRNA levels in brain areas involved in HPA axis control following short-term and long-term administration in normal and stressed rats.  Mol Psychiatry. 2001;  6 547-64
  CrossrefPubMedGoogle Scholar

Prof. Veronika Butterweck, PhD

Department of Pharmaceutics

PO 100 494

College of Pharmacy

University of Florida

Gainesville

FL 32610

USA

Phone: +1-362-846-2470

Fax: +1-362-392-4447

Email: butterwk@cop.ufl.edu